A new advanced cell sorting technology for cancer research
BD FACSDiscover S8: A multi-laser spectral cell sorter with BD CellView Image Technology
This study is all about making it easier and faster for researchers at Northwestern University to analyze and sort cells, especially for important cancer research, by using a new high-tech machine that helps them work with patient samples more efficiently.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10851132 on NIH RePORTER |
What this research studies
This research focuses on enhancing the capabilities of the Flow Cytometry Core Facility at Northwestern University by introducing a multi-laser spectral cell sorter. This advanced technology will allow for more efficient analysis and sorting of cells, which is crucial for cancer research and other biological studies. The facility aims to provide timely access to this technology for researchers, ensuring that they can work with human patient samples and other time-sensitive specimens without significant delays. By improving the sorting process, the research will facilitate better scientific interactions and productivity within the research community.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include patients with cancer or other conditions requiring detailed cellular analysis.
Not a fit: Patients who are not undergoing any form of cellular analysis or treatment that involves flow cytometry may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the efficiency and accuracy of cell sorting for cancer research, leading to better patient outcomes.
How similar studies have performed: Other research has successfully utilized advanced flow cytometry technologies, indicating a strong potential for this approach to yield significant advancements.
Where this research is happening
Chicago, United States
- Northwestern University at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Perlman, Harris R — Northwestern University at Chicago
- Study coordinator: Perlman, Harris R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.